Skip to main content
. Author manuscript; available in PMC: 2023 Dec 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2022 Dec 1;91(4):397–402. doi: 10.1097/QAI.0000000000003078

Table 1.

Baseline Characteristics by Treatment Arm

Participant Characteristics 3HP N = 256 (%) 3HR N = 252 (%) 6H N = 260 (%) H-Cont N = 128 (%)
Age, years, Mean (SD) 29.9 (6.1) 30.0 (5.5) 30.3 (6.2) 29.5 (5.6)
Baseline CD4, cell/mm3, Mean (SD) 546 (262) 569 (260) 540 (237) 537 (269)
Weight, kg, Mean (SD) 67.3 (14.6) 67.7 (13.9) 67.5 (14.4) 69.0 (15.0)
Height, cm, Mean (SD) 158.9 (5.9) 158.5 (5.5) 159.3 (6.3) 159.6 (6.8)
BMI, Mean (SD) 26.5 (5.5) 26.8 (5.2) 26.8 (5.4) 27.0 (5.6)
Race
African/Black 256 (100.0) 251 (99.6) 259 (99.6) 128 (100.0)
Colored 0 (0.0) 1 (0.4) 1 (0.4) 0 (0.0)
Education
None or Primary 13 (5.1) 12 (4.8) 7 (2.7) 11 (8.6)
Secondary and above 162 (63.3) 164 (65.1) 159 (61.2) 73 (57.0)
Grade 12/ Degree/ Diploma 81 (31.6) 76 (30.2) 94 (36.1) 44 (34.4)
Marital status
Married/Living Together 50 (19.6) 54 (21.4) 41 (15.8) 22 (17.1)
Divorced/Separated/Widowed 8 (3.1) 11 (4.3) 9 (3.5) 4 (3.1)
Single 198 (77.3) 187 (74.2) 210 (80.8) 102 (79.7)
Separated 2 (0.8) 3 (1.2) 2 (0.8) 0 (0.0)
Employment Status
Employed 28 (10.9) 28 (11.1) 26 (10.0) 12 (9.4)
Unemployed/Other 228 (89.1) 224 (88.9) 234 (90.0) 116 (90.6)
Smoking 43 (16.8) 35 (13.9) 49 (18.8) 20 (15.6)
Alcohol Consumption 45 (17.6) 45 (17.9) 66 (25.4) 29 (22.7)
Contraceptive Use
Overall 173 (67.6) 169 (67.1) 190 (73.1) 89 (69.5)
Injectable 104 (40.6) 92 (36.5) 108 (41.5) 57 (44.5)
Oral contraceptive 11 (4.3) 12 (4.8) 12 (4.6) 3 (2.3)
Loop/IUCD 1 (0.4) 1 (0.4) 2 (0.8) 1 (0.8)
Barrier (condom, cervical cap, diaphragm) 136 (53.1) 132 (52.4) 151 (58.1) 74 (57.8)
ART
Overall 45 (17.6) 46 (18.3) 46 (17.7) 26 (20.3)
ART during pregnancy 4 (1.6) 9 (3.6) 6 (2.3) 2 (1.6)
ART at contraception 2 (0.8) 6 (2.4) 4 (1.5) 2 (1.6)